0

Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD

Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD

Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD

By July 4, 2024

Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD

Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC With ILD

Current Status
Not Enrolled
Price
Free
Get Started

This course discusses the safety of stereotactic ablative radiotherapy in patients with early non-small cell lung cancer and interstitial lung disease.

Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.